ABCAM Plc Blocklisting Interim Review (3961O)
August 06 2014 - 5:00AM
UK Regulatory
TIDMABC
RNS Number : 3961O
ABCAM Plc
06 August 2014
ABCAM PLC
("Abcam" or "the Company")
Block Admission Return
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the
supply of protein research tools, makes the following notification
pursuant to Schedule Six of the AIM Rules for Companies regarding
its existing block admission arrangements:
Name of applicant: Abcam plc
---------------------------------------------------------------------------- ----------------------------------------
Name of scheme: 1. Abcam EMI Scheme
2. Abcam SAYE Scheme
3. Abcam 2005 Share Option Scheme
4. Abcam Share Incentive Plan
5. Abcam Company Share Option Plan
6. Abcam Long Term Incentive Plan
7. Annual Bonus Plan
---------------------------------------------------------------------------- ----------------------------------------
Period of return: From: 6 February 2014 To: 5 August 2014
---------------------------------------------------- ---------------------- ----------------- ----- --------------
Balance of unallotted securities under scheme(s) from previous return: 1. 570,015
2. 31,405
3. 3,053,594
4. 464,586
5. 787,132
6. 2,394,546
7. 399,479
---------------------------------------------------------------------------- ----------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the 1. -
date of the last 2. -
return (if any increase has been applied for): 3. -
4. -
5. -
6. -
7. -
---------------------------------------------------------------------------- ----------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period 1. 9,100
(see LR3.5.7G): 2. -
3. 286,835
4. -
5. 66,374
6. 358,493
7. -
---------------------------------------------------------------------------- ----------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 1. 560,915
2. 31,405
3. 2,766,759
4. 464,586
5. 720,758
6. 2,036,053
7. 399,479
---------------------------------------------------------------------------- ----------------------------------------
Name of contact: Jeff Iliffe, CFO
------------------------------ -----------------
Telephone number of contact: 01223 696000
------------------------------ -----------------
For further information please contact:
Abcam + 44 (0) 1223 696 000
Jeff Iliffe, Chief Financial Officer
Numis Securities - Nominated Adviser
& Joint Broker + 44 (0) 20 7260 1000
Michael Meade - Nominated Adviser
James Black - Corporate Broking
Peel Hunt LLP - Joint Broker + 44 (0) 20 7418 8900
Clare Terlouw / Jock Maxwell MacDonald
Brunswick + 44 (0) 20 7404 5959
Justine Mcllroy / Robin Wrench
Notes for editors:
About Abcam plc
Abcam plc is a leading provider of protein research tools and
services, with a wide range of products and expert technical
support, enabling scientists to analyse living cells at the
molecular level to improve the understanding of health and
disease.
Abcam is committed to providing scientists with access to the
correct reagents and tools for their research. The Company's
catalogue currently comprises more than 134,000 products and is
continually evolving to meet customer needs. The range offered
includes primary and secondary antibodies, proteins, peptides,
lysates, biochemicals, immunoassays and other kits. Abcam products
are supported with detailed, up-to-date and unbiased data on our
website.
Headquartered in Cambridge, UK, Abcam has eight global
subsidiary offices and ships to over 100 countries. The Company was
founded in 1998, and now employs over 700 people. Abcam is quoted
on the AIM market of the London Stock Exchange (AIM: ABC).
To find out more, please visit www.abcam.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRGIGDICUGBGSL
Abcam (LSE:ABC)
Historical Stock Chart
From Apr 2024 to May 2024
Abcam (LSE:ABC)
Historical Stock Chart
From May 2023 to May 2024
